Stay updated on Mocetinostat and Vinorelbine in Rhabdomyosarcoma Clinical Trial

Sign up to get notified when there's something new on the Mocetinostat and Vinorelbine in Rhabdomyosarcoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Mocetinostat and Vinorelbine in Rhabdomyosarcoma Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision label changes from v3.7.1 to v3.7.2; the study page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-19T14:11:55.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The site revision identifier in the footer changes from v3.7.0 to v3.7.1; the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-12T14:20:06.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Version update to Revision: v3.7.0 is shown, and a large block of terms and fields—such as regulatory status, the study drugs, disease/MeSH terms, and key eligibility/outcome descriptors—were removed from the page. This change alters how the study is described and indexed on ClinicalTrials.gov.
    Difference
    19%
    Check dated 2026-09-21T22:20:51.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    Revision label on the page updated from v3.6.5 to v3.6.6, indicating a newer page build.
    Difference
    0.1%
    Check dated 2026-08-31T17:34:04.000Z thumbnail image
  6. Check
    77 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.6.4 to v3.6.5, indicating a new version of the page. This change does not modify substantive content or functionality.
    Difference
    0.1%
    Check dated 2026-08-10T12:23:20.000Z thumbnail image
  7. Check
    91 days ago
    Change Detected
    Summary
    - Revision updated from v3.6.3 to v3.6.4, indicating a minor site update. The change does not alter study content or user-facing functionality.
    Difference
    0.1%
    Check dated 2026-07-27T05:38:29.000Z thumbnail image

Stay in the know with updates to Mocetinostat and Vinorelbine in Rhabdomyosarcoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Mocetinostat and Vinorelbine in Rhabdomyosarcoma Clinical Trial page.